A retrospective review of isolated gliptin-exposure cases reported to a state poison control system - Darracq MA, Toy JM, Chen T, Mo C, Cantrell FL.

Background. The dipeptidyl peptidase-4 (DPP-4) inhibitors sitagliptin, saxagliptin, and linagliptin are approved by the US Food and Drug Administration in the treatment of type-2 diabetes. Given the limited published information regarding human overdoses t...
Source: SafetyLit: All (Unduplicated) - Category: Global & Universal Tags: Poisoning Source Type: news